Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Catherine Mummery

7PUBLICATIONS
83CO-AUTHORS
AutoimmunityMechanobiologyMedical devicesBiologically active moleculesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Mar 05, 2026
The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial.

Catherine J Mummery, Arthur J Mayorga, Adam Simmons

|Feb 11, 2026
Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer's disease.

Melanie Shulman, Shuang Wu, Nick Ziogas

|Dec 13, 2025
Lecanemab appropriate use recommendations for clinical practice in the UK.

Catherine J Mummery, Jill Rasmussen, Dan Blackburn

|Feb 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial.

Randall J Bateman, Yan Li, Eric M McDade

|Oct 16, 2023
Author Correction: Tau-targeting antisense oligonucleotide MAPT<sub>Rx</sub> in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.

Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn

|Apr 24, 2023
Tau-targeting antisense oligonucleotide MAPT<sub>Rx</sub> in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.

Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn

Pageof 2

Frequent Collaborators

2 joint publications

Simon Ducharme

2 joint publications

Juha O Rinne

2 joint publications

Eric E Swayze

2 joint publications

Daniel A Norris

2 joint publications

Alison A Goate

2 joint publications

Brian A Gordon

2 joint publications

Tammie L S Benzinger

2 joint publications

Nick Fox

2 joint publications

Jorge J Llibre-Guerra

2 joint publications

Eric McDade

Frequent Collaborators

2 joint publications

Simon Ducharme

2 joint publications

Juha O Rinne

2 joint publications

Eric E Swayze

2 joint publications

Daniel A Norris

Top Related Videos

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on : Aug 14, 2016

9.7K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on : Jun 03, 2020

18.2K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on : Sep 16, 2018

10.7K
See more related videos

Top Related Videos

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on : Aug 14, 2016

9.7K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on : Jun 03, 2020

18.2K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on : Sep 16, 2018

10.7K
See more related videos